Defining and Predicting Response to Hypomethylating Agents in Myelodysplastic Syndrome

In this segment, panelists discuss the lack of a clear connection between response to hypomethylating agents and molecular genetics as well as the larger role for cytogenetic assessment of response for patients with myelodysplastic syndrome.